Literature DB >> 24118404

Progressive multifocal leukoencephalopathy: a rare infectious complication following allogeneic hematopoietic cell transplantation (HCT).

Gregory P Kaufman1, Allen J Aksamit, Christopher J Klein, Eunhee S Yi, David R Delone, Mark R Litzow.   

Abstract

Progressive multifocal leukoencephalopathy (PML), a demyelinating disorder caused by brain infection with JC virus, is a neurological complication of immunocompromised states and immunosuppressive therapies. While most commonly seen in the HIV/AIDS population, patients with hematologic malignancies are also at risk following treatment protocols including monoclonal antibodies such as rituximab and after hematopoietic stem cell transplantation. Here, we present the case of PML following allogeneic HCT that highlights potential diagnostic difficulties. We also review the literature regarding PML following HCT and described therapies employed to attempt to treat this disorder.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  allogeneic bone marrow transplantation; encephalitis; hematopoietic cell transplantation; immunocompromised host; progressive multifocal leukoencephalopathy

Mesh:

Year:  2013        PMID: 24118404     DOI: 10.1111/ejh.12208

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  6 in total

Review 1.  Treatment of membranous nephropathy: time for a paradigm shift.

Authors:  Piero Ruggenenti; Fernando C Fervenza; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2017-07-03       Impact factor: 28.314

2.  Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact.

Authors:  M R Dowling; S Li; B R Dey; S L McAfee; H R Hock; T R Spitzer; Y-B Chen; K K Ballen
Journal:  Bone Marrow Transplant       Date:  2017-11-13       Impact factor: 5.483

Review 3.  Neurologic Emergencies in the Patients With Cancer.

Authors:  Andrew L Lin; Edward K Avila
Journal:  J Intensive Care Med       Date:  2016-07-09       Impact factor: 3.510

4.  Efficacy of recombinant human interleukin 7 in a patient with severe lymphopenia-related progressive multifocal leukoencephalopathy.

Authors:  Jacques Gasnault; Marie-Ghislaine de Goër de Herve; Jean-Marie Michot; Houria Hendel-Chavez; Vannina Seta; Anne-Aurélie Mazet; Thérèse Croughs; Bruno Stankoff; Jean-Henri Bourhis; Olivier Lambotte; Jean-François Delfraissy; Yassine Taoufik
Journal:  Open Forum Infect Dis       Date:  2014-08-26       Impact factor: 3.835

5.  Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases.

Authors:  Roderick P P W M Maas; Annemarie H G Muller-Hansma; Rianne A J Esselink; Jean-Luc Murk; Clemens Warnke; Joep Killestein; Mike P Wattjes
Journal:  J Neurol       Date:  2016-07-11       Impact factor: 4.849

Review 6.  Virus-specific T-cell therapies for patients with primary immune deficiency.

Authors:  Michael D Keller; Catherine M Bollard
Journal:  Blood       Date:  2020-02-27       Impact factor: 25.476

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.